Clinical Trial Update: Treatment of Non-Tuberculous Mycobacterial Infections With Interferon Gamma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating interferon gamma for non-tuberculous mycobacterial infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-tuberculous Mycobacterial Infections

Drugs mentioned

• Interferon-gamma (interferon gamma)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Healthy, Mycobacterium Infections, Atypical | Phase 2 | Status: COMPLETED